Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 17461 - 17470 of 24215
| Identification Number | Trade Name | Benefit Category |
|---|---|---|
| 02410524 | MOMETASONE AQUEOUS NASAL SPRAY 50MCG/ACT | Standard Benefit for Eligible Clients |
| 02410567 | AURO-LAMIVUDINE TAB 300MG | Standard Benefit for Eligible Clients |
| 02410575 | AURO-LAMIVUDINE TAB 150MG | Standard Benefit for Eligible Clients |
| 02410656 | MYLAN-TADALAFIL 10MG TAB | Standard Benefit for Eligible Clients |
| 02410664 | MYLAN-TADALAFIL 20MG TAB | Standard Benefit for Eligible Clients |
| 02410702 | ZAXINE TAB 550MG | This is not a Standard Benefit. Special Authorization is required. |
| 02410745 | LORAZEPAM SUBLINGUAL TAB 0.5MG | Standard Benefit for Eligible Clients |
| 02410753 | LORAZEPAM SUBLINGUAL TAB 1MG | Standard Benefit for Eligible Clients |
| 02410761 | LORAZEPAM SUBLINGUAL TAB 2MG | Standard Benefit for Eligible Clients |
| 02410788 | ZAMINE 21 TAB | Standard Benefit for Eligible Clients |
Displaying 17461 - 17470 of 24215